Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrochlorothiazide for Anti-doping Control Samples
NCT04197622Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Mar 2019
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hydrochlorothiazide in hypertension (HTN) and edema, sponsored by Parc de Salut Mar. Primary endpoint: Urine concentration of hydrochlorothiazide. Started Mar 2019; status: completed.
02
Drugs
hydrochlorothiazide
03
Conditions
hypertension (HTN)edema
Beyond the preview
Go deeper on NCT04197622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04197622.